154 related articles for article (PubMed ID: 26164314)
1. Effect of Lid Debridement-Scaling in Sjögren Syndrome Dry Eye.
Ngo W; Caffery B; Srinivasan S; Jones LW
Optom Vis Sci; 2015 Sep; 92(9):e316-20. PubMed ID: 26164314
[TBL] [Abstract][Full Text] [Related]
2. Debridement-scaling: a new procedure that increases Meibomian gland function and reduces dry eye symptoms.
Korb DR; Blackie CA
Cornea; 2013 Dec; 32(12):1554-7. PubMed ID: 24145633
[TBL] [Abstract][Full Text] [Related]
3. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
Ozek D; Kemer OE; Omma A
Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
[TBL] [Abstract][Full Text] [Related]
4. Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren's syndrome patients and nondry eye controls.
Menzies KL; Srinivasan S; Prokopich CL; Jones L
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):836-41. PubMed ID: 25574045
[TBL] [Abstract][Full Text] [Related]
5. Meibomian gland dysfunction in patients with Sjögren syndrome.
Shimazaki J; Goto E; Ono M; Shimmura S; Tsubota K
Ophthalmology; 1998 Aug; 105(8):1485-8. PubMed ID: 9709762
[TBL] [Abstract][Full Text] [Related]
6. Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren's Syndrome.
Kim M; Kim HS; Na KS
Korean J Ophthalmol; 2017 Feb; 31(1):25-31. PubMed ID: 28243020
[TBL] [Abstract][Full Text] [Related]
7. Lid margins: sensitivity, staining, meibomian gland dysfunction, and symptoms.
Golebiowski B; Chim K; So J; Jalbert I
Optom Vis Sci; 2012 Oct; 89(10):1443-9. PubMed ID: 22922778
[TBL] [Abstract][Full Text] [Related]
8. Effect of using a combination of lid wipes, eye drops, and omega-3 supplements on meibomian gland functionality in patients with lipid deficient/evaporative dry eye.
Korb DR; Blackie CA; Finnemore VM; Douglass T
Cornea; 2015 Apr; 34(4):407-12. PubMed ID: 25651491
[TBL] [Abstract][Full Text] [Related]
9. Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome.
Chen X; Utheim ØA; Xiao J; Adil MY; Stojanovic A; Tashbayev B; Jensen JL; Utheim TP
PLoS One; 2017; 12(9):e0184284. PubMed ID: 28886085
[TBL] [Abstract][Full Text] [Related]
10. Meibomian gland dropout in Sjögren's syndrome and non-Sjögren's dry eye patients.
Zang S; Cui Y; Cui Y; Fei W
Eye (Lond); 2018 Nov; 32(11):1681-1687. PubMed ID: 29934634
[TBL] [Abstract][Full Text] [Related]
11. Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.
Kang YS; Lee HS; Li Y; Choi W; Yoon KC
Int Ophthalmol; 2018 Jun; 38(3):1161-1167. PubMed ID: 28567496
[TBL] [Abstract][Full Text] [Related]
12. A randomized, sham-controlled trial of intraductal meibomian gland probing with or without topical antibiotic/steroid for obstructive meibomian gland dysfunction.
Kheirkhah A; Kobashi H; Girgis J; Jamali A; Ciolino JB; Hamrah P
Ocul Surf; 2020 Oct; 18(4):852-856. PubMed ID: 32882429
[TBL] [Abstract][Full Text] [Related]
13. Serologic Markers Are Associated With Ocular Staining Score in Primary Sjögren Syndrome.
Lim SA; Nam S; Kwok SK; Park SH; Chung SH
Cornea; 2015 Nov; 34(11):1466-70. PubMed ID: 26356755
[TBL] [Abstract][Full Text] [Related]
14. Tear Lysozyme in Sjögren´s syndrome, Meibomian gland dysfunction, and non-dry-eye.
Berra M; Galperín G; Berra F; Marquez MI; Mandaradoni M; Tau J; Berra A
Arq Bras Oftalmol; 2021; 85(2):103-108. PubMed ID: 34431892
[TBL] [Abstract][Full Text] [Related]
15. Association of meibomian gland morphology with symptoms and signs of dry eye disease in the Dry Eye Assessment and Management (DREAM) study.
Daniel E; Pistilli M; Ying GS; Bunya VY; Massaro-Giordano M; Asbell PA; Maguire MG;
Ocul Surf; 2020 Oct; 18(4):761-769. PubMed ID: 32858234
[TBL] [Abstract][Full Text] [Related]
16. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
[TBL] [Abstract][Full Text] [Related]
17. Tear lipid layer thickness and ocular comfort with a novel device in dry eye patients with and without Sjögren's syndrome.
Spiteri A; Mitra M; Menon G; Casini A; Adams D; Ricketts C; Hickling P; Fuller ET; Fuller JR
J Fr Ophtalmol; 2007 Apr; 30(4):357-64. PubMed ID: 17486027
[TBL] [Abstract][Full Text] [Related]
18. A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months.
Greiner JV
Curr Eye Res; 2012 Apr; 37(4):272-8. PubMed ID: 22324772
[TBL] [Abstract][Full Text] [Related]
19. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
[TBL] [Abstract][Full Text] [Related]
20. Tear physiology in dry eye associated with chronic GVHD.
Khanal S; Tomlinson A
Bone Marrow Transplant; 2012 Jan; 47(1):115-9. PubMed ID: 21383687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
